| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,127 |
6,477 |
$531K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,847 |
3,584 |
$205K |
| 90691 |
|
882 |
861 |
$88K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
432 |
423 |
$36K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,927 |
2,784 |
$34K |
| 90717 |
|
273 |
265 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
5,842 |
5,432 |
$24K |
| 99402 |
|
491 |
480 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,197 |
1,140 |
$17K |
| 80053 |
Comprehensive metabolic panel |
1,101 |
1,063 |
$11K |
| 99215 |
Prolong outpt/office vis |
80 |
75 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
341 |
332 |
$9K |
| 80061 |
Lipid panel |
599 |
586 |
$8K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
128 |
128 |
$7K |
| 99401 |
|
275 |
272 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
76 |
75 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
668 |
659 |
$6K |
| 90686 |
|
632 |
625 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
319 |
313 |
$5K |
| 85027 |
|
693 |
663 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
117 |
116 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
24 |
24 |
$2K |
| 96127 |
|
441 |
415 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
79 |
78 |
$2K |
| 82728 |
|
86 |
84 |
$1K |
| 86803 |
|
79 |
79 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 90734 |
|
31 |
31 |
$869.28 |
| 99441 |
|
56 |
30 |
$769.38 |
| 90682 |
|
15 |
15 |
$697.51 |
| 99442 |
|
29 |
18 |
$591.33 |
| 92551 |
|
90 |
86 |
$513.98 |
| 0054A |
|
12 |
12 |
$468.71 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
13 |
13 |
$450.19 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$363.38 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$363.38 |
| 90480 |
|
12 |
12 |
$344.13 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55 |
52 |
$254.79 |
| 90707 |
|
14 |
12 |
$239.37 |
| 87210 |
|
37 |
36 |
$224.00 |
| 99188 |
|
13 |
13 |
$147.64 |
| 99173 |
|
118 |
114 |
$135.72 |
| 81025 |
|
12 |
12 |
$108.52 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12 |
12 |
$102.14 |
| 82043 |
|
12 |
12 |
$70.50 |
| 81001 |
|
14 |
14 |
$46.09 |
| X5622 |
|
62 |
61 |
$0.00 |
| 91312 |
|
16 |
15 |
$0.00 |
| 99421 |
|
14 |
12 |
$0.00 |